GlassScriptPhysician profile
Lisa H Thompson
NPI 1376631903
$655.86
in general payments reported to CMS, 2019-2025
17 companies · $36.69 in 2025
The $36.69 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.91 · 2022: $145 · 2023: $77.35 · 2024: $302 · 2025: $36.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $93.36 | 2022-2024 | Lucemyra |
| Abbvie INC. | $80.28 | 2021 | |
| Tris Pharma INC | $74.31 | 2024-2025 | Dyanavel Xr |
| Lundbeck LLC | $57.60 | 2024 | Rexulti |
| Indivior INC. | $44.09 | 2022 | |
| Alkermes, INC. | $43.91 | 2022-2024 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $35.34 | 2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Eisai INC. | $35.27 | 2024 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $30.46 | 2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $29.78 | 2023 | Hetlioz, Fanapt |
| Neurocrine Biosciences, INC. | $19.50 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.36 | 2022 | |
| Integra Lifesciences Corporation | $17.11 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pfizer INC. | $15.54 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.63 | 2021 | |
| Lilly USA, LLC | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.